ARCHIVES

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 39 No. 26 | June 26, 2013

Download PDF Visit The Full Archive

Related Articles

Working Group to Look At Guidelines, Mandates, Centers Role In Prevention, Cancer Control

February 17, 1984

“Forward Funding” Will Cost NCI $38 Million, 270 Grants, As OMB Legally Impounds FY 1985 Money

February 1, 1985

Campath Improves PFS In B-Cell CLL In Phase III Trial

January 26, 2007

HHS Appoints 13 To Genetics Committee

January 17, 2003

DCPC Advisors Okay Omnibus Prevention Program Announcement

January 24, 1992

Gene Expression Analyses Can Guide MDS Treatments

December 30, 2011